1. Home
  2. CGTX vs RETO Comparison

CGTX vs RETO Comparison

Compare CGTX & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • RETO
  • Stock Information
  • Founded
  • CGTX 2007
  • RETO 1999
  • Country
  • CGTX United States
  • RETO China
  • Employees
  • CGTX N/A
  • RETO N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • CGTX Health Care
  • RETO Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • RETO Nasdaq
  • Market Cap
  • CGTX 17.9M
  • RETO 19.9M
  • IPO Year
  • CGTX 2021
  • RETO 2017
  • Fundamental
  • Price
  • CGTX $0.43
  • RETO $5.41
  • Analyst Decision
  • CGTX Strong Buy
  • RETO
  • Analyst Count
  • CGTX 6
  • RETO 0
  • Target Price
  • CGTX $8.30
  • RETO N/A
  • AVG Volume (30 Days)
  • CGTX 2.8M
  • RETO 1.1M
  • Earning Date
  • CGTX 05-06-2025
  • RETO 10-28-2024
  • Dividend Yield
  • CGTX N/A
  • RETO N/A
  • EPS Growth
  • CGTX N/A
  • RETO N/A
  • EPS
  • CGTX N/A
  • RETO N/A
  • Revenue
  • CGTX N/A
  • RETO $3,841,142.00
  • Revenue This Year
  • CGTX N/A
  • RETO N/A
  • Revenue Next Year
  • CGTX N/A
  • RETO N/A
  • P/E Ratio
  • CGTX N/A
  • RETO N/A
  • Revenue Growth
  • CGTX N/A
  • RETO N/A
  • 52 Week Low
  • CGTX $0.34
  • RETO $0.33
  • 52 Week High
  • CGTX $2.95
  • RETO $7.10
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 27.35
  • RETO 44.14
  • Support Level
  • CGTX $0.36
  • RETO $5.20
  • Resistance Level
  • CGTX $0.45
  • RETO $10.70
  • Average True Range (ATR)
  • CGTX 0.05
  • RETO 2.68
  • MACD
  • CGTX -0.01
  • RETO 0.20
  • Stochastic Oscillator
  • CGTX 23.66
  • RETO 23.86

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: